SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-004676
Filing Date
2023-02-27
Accepted
2023-02-27 16:32:58
Documents
6
Effectiveness Date
2023-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_-_evergreen_and_indu.htm S-8 159350
2 EX-5.1 stro-ex5_1.htm EX-5 20764
3 EX-23.1 stro-ex23_1.htm EX-23 4752
4 EX-99.5 stro-ex99_5.htm EX-99 195713
5 EX-FILING FEES stro-exfiling_fees.htm EX-FILING FEES 42941
6 GRAPHIC img4916824_0.jpg GRAPHIC 32230
  Complete submission text file 0000950170-23-004676.txt   469122
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270055 | Film No.: 23675506
SIC: 2836 Biological Products, (No Diagnostic Substances)